FDA approves Movantik for opioid-induced constipation

The U.S. Food and Drug Administration has approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain.
Pain / Anesthetics News From Medical News Today

Share:

Related Content